EVALUATION AND COMPARISON OF EFFectiveness AND SKIN SAFETY during use OF 3 ANTI-Pimple TEST PRODUCTS (SOFINOX CREAM, SOFINOX RD CREAM AND CLINDAC A GEL) ON MILD TO MODERATE Pimples.
- Registration Number
- CTRI/2012/04/002569
- Lead Sponsor
- Apex Laboratories Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 96
1.Voluntary men/women with inflammatory acne lesions (5 - 25) on entire face.
2.Age between 18 â?? 55
3.No treatment for acne in the past 1 month
4.Phototype III and IV.
5.All skin types (greasy, normal) except sensitive skin.
6.Accepting not to use products with the same end benefit during the entire study duration.
7.For whom the Investigator considers that the compliance will be correct.
8.Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures.
9.Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.
1.Pregnant women (as confirmed by UPT) and lactating women.
2.History suggestive of any hormonal problems.
3.History of allergic dermatitis or contact allergy to cosmetics,
4.Subjects on oral retinoid since the past 3 months.
5.Hypersensitivity to any cosmetic product, raw material.
6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures.
7.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
8.Subject in an exclusion period or participating in another similar cosmetic or therapeutic trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method